| Inflammation in cystic fibrosis: An update |
33 |
| Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy |
27 |
| Lung ultrasound score as early predictor of bronchopulmonary dysplasia in very low birth weight infants |
14 |
| Lung ultrasound features of children with complicated and noncomplicated community acquired pneumonia: A prospective study |
13 |
| Mucus obstruction and inflammation in early cystic fibrosis lung disease: Emerging role of the IL-1 signaling pathway |
13 |
| Sleep disordered breathing and ventilatory support in children with Down syndrome |
13 |
| Lung ultrasonography score versus chest X-ray score to predict surfactant administration in newborns with respiratory distress syndrome |
11 |
| Does lung microbiome play a causal or casual role in asthma? |
10 |
| Lung ultrasound compared to chest X-ray for diagnosis of pediatric pneumonia: A meta-analysis |
10 |
| Point of care diaphragm ultrasound in infants with bronchiolitis: A prospective study |
10 |
| Cystic fibrosis precision therapeutics: Emerging considerations |
10 |
| Severe asthma in children-a review of definitions, epidemiology, and treatment options in 2019 |
9 |
| Elevated lung volumes in neonates with bronchopulmonary dysplasia measured via MRI |
9 |
| Surfactant therapy in premature babies: SurE or InSurE |
9 |
| Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators |
9 |
| Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants |
9 |
| Outpatient initiation of long-term continuous positive airway pressure in children |
8 |
| Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma |
8 |
| Pulmonary presentation of Kawasaki diseaseA diagnostic challenge |
8 |
| Role of prophylactic azithromycin to reduce airway inflammation and mortality in a RSV mouse infection model |
8 |
| The relationship between inflammation and remodeling in childhood asthma: A systematic review |
8 |
| Molecular and clinical characteristics of severe Mycoplasma pneumoniae pneumonia in children |
8 |
| An investigation into biomarkers for the diagnosis of ABPA and aspergillus disease in cystic fibrosis |
8 |
| Tracheal aspirate VEGF and sphingolipid metabolites in the preterm infant with later development of bronchopulmonary dysplasia |
8 |
| Children with severe acute asthma admitted to Dutch PICUs: A changing landscape |
8 |
| Decrease the flow setting to improve trans-nasal pulmonary aerosol delivery via high-flow nasal cannula to infants and toddlers |
7 |
| Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor |
7 |
| Utility and safety of endobronchial ultrasound-guided transbronchial needle aspiration and endoscopic ultrasound with an echobronchoscope-guided fine needle aspiration in children with mediastinal pathology |
7 |
| Time for a gut check: Pancreatic sufficiency resulting from CFTR modulator use |
7 |
| Lung function after extremely preterm birthA population-based cohort study (EXPRESS) |
7 |
| Physiological and anatomical dead space in mechanically ventilated newborn infants |
7 |
| Predictors of sleep hypoxemia in children with cystic fibrosis |
7 |
| Complications and risk factors in pediatric bronchoscopy in a tertiary pediatric respiratory center |
7 |
| The use of pharmacogenomics, epigenomics, and transcriptomics to improve childhood asthma management: Where do we stand? |
7 |
| Oxygen saturation/FIO2 ratio at 36 weeks' PMA in 1005 preterm infants: Effect of gestational age and early respiratory disease patterns |
7 |
| Global prevalence of exercise-induced bronchoconstriction in childhood: A meta-analysis |
7 |
| Trends in epidemiology and outcomes of respiratory distress syndrome in the United States |
7 |
| Divergent transcriptional profiles in pediatric asthma patients of low and high socioeconomic status |
7 |
| Deposition studies of aerosol delivery by nasal cannula to infants |
6 |
| Microbiome characteristics of induced sputum compared to bronchial fluid and upper airway samples |
6 |
| Pediatric patients with home mechanical ventilation: The health services landscape |
6 |
| Children with poorly controlled asthma: Randomized controlled trial of a home-based environmental control intervention |
6 |
| Treatment of severe bronchiolitis: A survey of Canadian pediatric intensivists |
6 |
| Medication adherence in pediatric asthma: A systematic review of the literature |
6 |
| Rapid therapeutic advances in CFTR modulator science |
6 |
| The myriad challenges of respiratory fungal infection in cystic fibrosis |
6 |
| Major depression and psychiatric comorbidity in Turkish children and adolescents with cystic fibrosis |
6 |
| Neonatal swallowing assessment using fiberoptic endoscopic evaluation of swallowing (FEES) |
6 |
| Prediction of peak oxygen uptake using the modified shuttle test in children and adolescents with cystic fibrosis |
6 |
| In children, the microbiota of the nasopharynx and bronchoalveolar lavage fluid are both similar and different |
6 |
